Biolife stock

May 10, 2023 · BioLife Solutions Reports First Quarter 2023 Financial Results. Revenue of $37.7 million increased 4% over Q1 2022, ex-COVID growth of 16% and biopreservation media revenue growth of 28%. Q1 2023 ... .

Congenital TTP is a life-threatening, rare genetic disorder with debilitating chronic symptoms. Find the latest Takeda Pharmaceutical Company Limited (TAK) stock quote, history, news and other ...The stock information provided is for informational purposes only and is not intended for trading purposes. BioLife Sciences is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors.WebBioLife shares outstanding (as of March 19, 2021) 33,401,359 Merger consideration percentage 19.9 % Merger consideration shares 6,646,870 less: Merger consideration shares withheld to satisfy outstanding GCI stockholder obligations to GCI 10,400 Subtotal 6,636,470 BioLife stock price (as of May 3, 2021) $ 35.07 Value of issued shares $ …

Did you know?

Stock analysis for BioLife Solutions Inc (BLFS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.BioLife shares outstanding (as of March 19, 2021) 33,401,359 Merger consideration percentage 19.9 % Merger consideration shares 6,646,870 less: Merger consideration shares withheld to satisfy outstanding GCI stockholder obligations to GCI 10,400 Subtotal 6,636,470 BioLife stock price (as of May 3, 2021) $ 35.07 Value of issued shares $ …Evogene Ltd. -0.32%. $32.76M. BLFS | Complete BioLife Solutions Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. See BioLife Solutions, Inc. (BLFS) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.

The estimated net worth of Roderick de Greef is at least $463,582.14 as of November 30th, 2022. Mr. de Greef owns 34,314 shares of BioLife Solutions stock worth more than $463,582 as of November 20th. This net worth estimate does not reflect any other investments that Mr. de Greef may own.WebFiscal Q3 2023 ended 9/30/23. Reported on 11/9/23. Get the latest BioLife Solutions Inc (BLFS) real-time quote, historical performance, charts, and other financial information to …View BioLife Solutions, Inc BLFS investment & stock information. Get the latest BioLife Solutions, Inc BLFS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.WebHENDERSON, NV, June 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioLife Sciences Inc. (OTC: BLFE) (the “Company” or “BioLife”), announced today that... OTC.VN : 0.345 (unch) BLFE : 0.0001 (unch) BioLife Sciences Inc. (OTC: Markets: BLFE) Announced Today that the Company has Introduced Copper Infused Gardening Gloves to its Newly ...

Oral Biolife is an innovative biotechnology company out of Temple University that utilizes the unique properties of Piezo materials to develop groundbreaking, first-to-market products. Their lead ...Thinly traded micro cap BioLife Solutions (NASDAQ:BLFS -15.6%) has increased its stake in SAVSU Technologies to 44% with a $5M investment.No changes to the price of Biolife Sciences Inc stock on the last trading day (Thursday, 30th Nov 2023). During the last trading day the stock fluctuated 100.00% from a day low at $0.0001 to a day high of $0.0002. The price has risen in 4 of the last 10 days and is up by 14900% over the past 2 weeks. ….

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Biolife stock. Possible cause: Not clear biolife stock.

Related to this, apart from some occasional sell to cover stock sales transactions to cover taxes for upcoming vesting events, my longstanding portfolio diversification plan sales are now complete. This is a great moment for BioLife and the cell and gene industry in a difficult macro and public market environment.Biolife Solutions story: Exercise or conversion by Karen Foster of 16332 shares of Biolife Solutions subject to Rule 16b 3 and other headlines for Biolife Solutions

BioLife Solutions Reports First Quarter 2023 Financial Results. Revenue of $37.7 million increased 4% over Q1 2022, ex-COVID growth of 16% and biopreservation media revenue growth of 28%. Q1 2023 ...BioLife was founded as Trans Time Medical Products in 1987 and went public in 1989, raising net proceeds of $4.6 million at $105 per share (after giving effect to 1-for-five (2000) and 1-for-14 ...BioLife Solutions Debt Current yearly trend continues to be comparatively stable with very little volatility. Debt Current will likely drop to about 4.2 M in 2023. From the period from 2010 to 2023, BioLife Solutions Debt Current quarterly data regression had r-squared of 0.57 and coefficient of variation of 91.26.At this time, BioLife Solutions' Selling General and …

reit best dividend Wall Street Stock Market & Finance report, prediction for the future: You'll find the Biolife Solutions share forecasts, stock quote and buy / sell signals below. According to present data Biolife Solutions's BLFS shares and potentially its market environment have been in bearish cycle last 12 months (if exists).BioLife Solutions is trading near 52-week lows as its growth story has floundered and profitability remains uncertain. Learn why I rate BLFS stock a hold.Web adob stockthe sphere las vegas capacity BioLife Solutions (NASDAQ:BLFS) is an emerging life sciences company which benefits from a large biopreservation media platform and several other product lines.It currently has a $25 million ...The estimated total pay for a Center Manager at Biolife Plasma Services is $68,682 per year. This number represents the median, which is the midpoint of the ranges from our proprietary Total Pay Estimate model and based on salaries collected from our users. ... Additional pay could include bonus, stock, commission, profit sharing or tips. … stock ery BioLife Sciences Inc. is a commercialization accelerator, licensor and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. The Company's core business develops, licenses and distributes antimicrobial products and disruptive technology.Mar 23, 2023 · Broadridge Corporate Issuer Solutions, Inc. P.O. Box 1342 Brentwood, New York 11717 USA (877) 830 - 4936 [email protected] bank account with instant debit cardprincpal 401ktdameritrade forex Open 18.44. Day High 18.95. Day Low 18.17. Prev Close 18.25. 52 Week High 26.96. 52 Week High Date 09/08/22. 52 Week Low 10.40. 52 Week Low Date 05/12/22. Market Cap 812.385M.Web arsan Nov 30, 2023 · See the latest BioLife Solutions Inc stock price (BLFS:XNAS), related news, valuation, dividends and more to help you make your investing decisions. best ira funds to invest intesla stock live chartvroom customer service Find the latest analyst research for Biolife Sciences Inc (BLFE) at Nasdaq.com.Rhumbline Advisers decreased its holdings in BioLife Solutions, Inc. (NASDAQ:BLFS – Free Report) by 8.1% in the second quarter, Holdings Channel.com reports. The institutional investor owned 80,251 shares of the medical equipment provider’s stock after selling 7,097 shares during the period. Rhumbline Advisers’ holdings in …Web